200 related articles for article (PubMed ID: 26846697)
21. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.
Zhou X; Chen J; Yi G; Deng M; Liu H; Liang M; Shi B; Fu X; Chen Y; Chen L; He Z; Wang J; Liu J
Oncotarget; 2016 Jan; 7(1):873-84. PubMed ID: 26621849
[TBL] [Abstract][Full Text] [Related]
22. C0818, a novel curcumin derivative, induces ROS-dependent cytotoxicity in human hepatocellular carcinoma cells in vitro via disruption of Hsp90 function.
Abdelmoaty AAA; Zhang P; Lin W; Fan YJ; Ye SN; Xu JH
Acta Pharmacol Sin; 2022 Feb; 43(2):446-456. PubMed ID: 33824458
[TBL] [Abstract][Full Text] [Related]
23. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
[TBL] [Abstract][Full Text] [Related]
24. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.
Xia L; Mo P; Huang W; Zhang L; Wang Y; Zhu H; Tian D; Liu J; Chen Z; Zhang Y; Chen Z; Hu H; Fan D; Nie Y; Wu K
Carcinogenesis; 2012 Nov; 33(11):2250-9. PubMed ID: 22831955
[TBL] [Abstract][Full Text] [Related]
25. Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90.
Trisciuoglio D; Gabellini C; Desideri M; Ziparo E; Zupi G; Del Bufalo D
PLoS One; 2010 Jul; 5(7):e11772. PubMed ID: 20668552
[TBL] [Abstract][Full Text] [Related]
26. Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α.
Zhao J; Lin E; Cai C; Zhang M; Li D; Cai S; Zeng G; Yin Z; Wang B; Li P; Hong X; Chen J; Zou B; Li J
Drug Des Devel Ther; 2022; 16():3197-3213. PubMed ID: 36158238
[TBL] [Abstract][Full Text] [Related]
27. Structural basis for depletion of heat shock protein 90 client proteins by deguelin.
Oh SH; Woo JK; Yazici YD; Myers JN; Kim WY; Jin Q; Hong SS; Park HJ; Suh YG; Kim KW; Hong WK; Lee HY
J Natl Cancer Inst; 2007 Jun; 99(12):949-61. PubMed ID: 17565155
[TBL] [Abstract][Full Text] [Related]
28. Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells.
Xu LF; Ni JY; Sun HL; Chen YT; Wu YD
World J Gastroenterol; 2013 Mar; 19(11):1749-59. PubMed ID: 23555163
[TBL] [Abstract][Full Text] [Related]
29. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop.
Cui CP; Wong CC; Kai AK; Ho DW; Lau EY; Tsui YM; Chan LK; Cheung TT; Chok KS; Chan ACY; Lo RC; Lee JM; Lee TK; Ng IOL
Gut; 2017 Dec; 66(12):2149-2159. PubMed ID: 28258134
[TBL] [Abstract][Full Text] [Related]
30. Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma.
Li XP; Yang XY; Biskup E; Zhou J; Li HL; Wu YF; Chen ML; Xu F
Oncotarget; 2015 Sep; 6(26):22880-9. PubMed ID: 26078356
[TBL] [Abstract][Full Text] [Related]
31. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein.
Song X; Yao J; Wang F; Zhou M; Zhou Y; Wang H; Wei L; Zhao L; Li Z; Lu N; Guo Q
Toxicol Appl Pharmacol; 2013 Sep; 271(2):144-55. PubMed ID: 23707765
[TBL] [Abstract][Full Text] [Related]
32. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of HIF-1α and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells.
Choi SH; Park JY; Kang W; Kim SU; Kim do Y; Ahn SH; Ro SW; Han KH
Apoptosis; 2016 Jan; 21(1):85-95. PubMed ID: 26467924
[TBL] [Abstract][Full Text] [Related]
34. Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma.
Herzog J; Ehrlich SM; Pfitzer L; Liebl J; Fröhlich T; Arnold GJ; Mikulits W; Haider C; Vollmar AM; Zahler S
Oncotarget; 2016 May; 7(19):27108-21. PubMed ID: 27027353
[TBL] [Abstract][Full Text] [Related]
35. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
36. Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling.
Saber S; El-Fattah EEA; Abdelhamid AM; Mourad AAE; Hamouda MAM; Elrabat A; Zakaria S; Haleem AA; Mohamed SZ; Elgharabawy RM; Morsy NE; El Adle Khalaf N; Mohammed OA; El-Bahouty WB; Mostafa SA; Abdelhady R; Galal O; ElSaid ZH; Yahya G; Shata A; Youssef ME
Biomed Pharmacother; 2023 Feb; 158():114196. PubMed ID: 36916405
[TBL] [Abstract][Full Text] [Related]
37. Silencing of HIF-1α inhibited the expression of lncRNA NEAT1 to suppress development of hepatocellular carcinoma under hypoxia.
Zhang X; Kang Z; Xie X; Qiao W; Zhang L; Gong Z; Chen Y; Shen W
Am J Transl Res; 2020; 12(7):3871-3883. PubMed ID: 32774741
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca
Dou C; Zhou Z; Xu Q; Liu Z; Zeng Y; Wang Y; Li Q; Wang L; Yang W; Liu Q; Tu K
Oncogene; 2019 Feb; 38(8):1239-1255. PubMed ID: 30250300
[TBL] [Abstract][Full Text] [Related]
39. Immunoexpression patterns for Hypoxia-inducible Factor-1α and von Hippel-Lindau protein, in relation to Hsp90, of human brain tumors.
Assimakopoulou M; Androutsopoulou C; Zolota V; Matsoukas J
Histol Histopathol; 2016 May; 31(5):535-46. PubMed ID: 26592496
[TBL] [Abstract][Full Text] [Related]
40. TRIM14 Overexpression Induces Chemoresistance and Malignant Behaviors of Hepatocellular Carcinoma Cells by Activating the STAT3/HIF-1α Pathway.
Xu W; Zhuang L; Zhu H; Mao A; Zhou J; Wang L
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]